Aspire Capital Fund LLC 13D and 13G filings for Mereo BioPharma Group plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2020-07-02 06:19 am Purchase |
2020-06-30 | 13G | Mereo BioPharma Group plc MREO |
Aspire Capital Fund LLC | 20,680,882 6.110% |
20,680,882 (New Position) |
Filing |